Progress in management of low-risk prostate cancer: how registries may change the world. Read more about Progress in management of low-risk prostate cancer: how registries may change the world.
Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Read more about Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Read more about Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature.
The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Read more about The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
European Urology: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review. Read more about European Urology: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review.
Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, t Read more about Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, t
European Association of Urology (@Uroweb) recommendations on the appropriate use of social media. Read more about European Association of Urology (@Uroweb) recommendations on the appropriate use of social media.
Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. Read more about Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Read more about A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Read more about Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
